Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,195 | 20,059 | 27,050 | 36,982 | 40,840 |
| Marketable Securities | 110 | 111 | 122 | 122 | 120 |
| Receivables | 129 | 262 | 638 | N/A | 373 |
| TOTAL | $13,032 | $22,754 | $29,302 | $39,740 | $44,324 |
| Non-Current Assets | |||||
| PPE Net | 999 | 1,039 | 1,090 | 1,120 | 1,148 |
| Other Non-Current Assets | 229 | 231 | 255 | 267 | 272 |
| TOTAL | $1,228 | $1,270 | $1,345 | $1,387 | $1,420 |
| Total Assets | $14,260 | $24,024 | $30,647 | $41,127 | $45,744 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,705 | 6,247 | 5,357 | 6,472 | 5,867 |
| TOTAL | $5,705 | $6,247 | $5,357 | $6,472 | $5,867 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 396 | 414 | 472 | 497 | 493 |
| TOTAL | $396 | $414 | $472 | $497 | $493 |
| Total Liabilities | $6,101 | $6,661 | $5,829 | $6,969 | $6,360 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,821 | 14,768 | 14,085 | 14,080 | 13,935 |
| Common Shares | 139 | 139 | 139 | 139 | 135 |
| Retained earnings | -139,566 | -129,378 | -121,168 | -111,141 | -101,092 |
| TOTAL | $8,159 | $17,363 | $24,818 | $34,158 | $39,384 |
| Total Liabilities And Equity | $14,260 | $24,024 | $30,647 | $41,127 | $45,744 |